Transcrocetinate disodium is primarily used in medical and pharmaceutical research due to its potential therapeutic properties. It has been studied for its ability to enhance oxygen delivery to tissues, making it a candidate for treating conditions like stroke, traumatic brain injury, and other ischemia-related disorders. Additionally, it has shown promise in improving the efficacy of certain cancer treatments by increasing oxygenation in tumor tissues, which can enhance the effects of radiation therapy. Its role in reducing inflammation and oxidative stress further supports its potential application in neurodegenerative diseases and other chronic conditions. Ongoing research continues to explore its broader clinical uses and safety profile.